beta-Pyridylcarbinol (Ronicol) releases a prostacyclin-like substance into arterial blood of patients with arteriosclerosis obliterans

Pharmacol Res Commun. 1983 Apr;15(4):377-85. doi: 10.1016/s0031-6989(83)80047-2.

Abstract

Beta-pyridylcarbinol (Ronicol) when injected (1,2-1,4 mg/kg i.v.) into four patients with arteriosclerosis obliterans caused a release of an unstable disaggregatory substance into arterial blood of those patients. This release was not observed in other two patients who had been pretreated with aspirin (1,8 g p.o.daily). It is postulated that some of pharmacological properties of nicotinic acid derivatives are mediated through the release of endogenous PGI2-like substance.

MeSH terms

  • Arteriosclerosis Obliterans / blood*
  • Epoprostenol / blood*
  • Humans
  • Lipid Peroxides / toxicity
  • Nicotinyl Alcohol / pharmacology*
  • Platelet Aggregation / drug effects
  • Prostaglandins / blood*
  • Pyridines / pharmacology*

Substances

  • Lipid Peroxides
  • Prostaglandins
  • Pyridines
  • Nicotinyl Alcohol
  • Epoprostenol